Press release: Sequana Medical announces H1 2025 results and provides business update
-
最新报道：Sequana Medical has commenced US commercialization of its alfapump system following December 2024 PMA approval, with CMS granting NTAP "top-up" reimbursement of up to $21,450 effective October 2025. The company aims for at least 70 commercial implants during its Soft Launch phase through Q1 2026, supported by a dedicated US team and advanced discussions with over ten hospitals. Financial highlights include €7.3 million liquidity as of June 2025 and a €2 million debt reduction through loan conversions.
下一篇
SPIE launches its employee shareholding plan SHARE FOR YOU 2025
- SPIE has launched its 9th employee shareholding plan, SHARE FOR YOU, offering over 49,000 ...
24小时热点
热点专题
416658